Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL-Reference-Cited by-同舟云学术

Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL

Published:2018 Issue: Volume:9 Page:5-8
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Abid Muhammad Bilal,Wadhera Karan,Bird Jenny M.,Pawade Joya,Marks David I.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference10 articles.

1. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies;Lehmberg;Haematologica,2015

2. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages;Emile;Blood,2016

3. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis;Henter;Pediatr. Blood Cancer,2007

4. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial;Moorman;Blood,2007

5. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab;Marsh;Pediatr. Blood Cancer,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT;RadioGraphics;2021-03

2. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets?;Pediatric Hematology and Oncology;2020-09-08